Insuffisance cardiaque : du risque à la prise en charge

Jeudi 13 Janvier 2022   10:00-11:00   Espace E-posters
JESFC 2022   |   Communication orale
10:00 • Barnabas Gellen
Elevated serum S100A12 levels are associated with increased risk of heart failure in patients with type 2 diabetes: the SURDIAGENE prospective study.
10:07 • Théo Pezel
A New Imaging Marker to Predict Incident Heart Failure: Annual Change in Left Atrioventricular Coupling Index A cardiovascular MRI report from the Multi-Ethnic Study of Atherosclerosis (MESA)
Patrick Jourdain
10:14 • Patrick Jourdain
 Influence of  chronic heart failure patient phenotypes on referring by general practitioners to office-based cardiologists (MIRROR-HF)
Voir la présentation
10:21 • Montse Massot
The benefit of genetic testing using next-generation sequencing in patients with dilated cardiomyopathies: a multi-centric international study
Voir la présentation
10:28 • Michel Galinier
Efficacy of Empagliflozin in the EMPEROR-Reduced Trial According to Dose and Combination of Baseline Heart Failure Therapies
Voir la présentation
10:35 • Audrey Poulat
Prognostic value of soluble ST2 in chronic heart failure
Voir la présentation
10:42 • Guillaume Coutance
Development and validation of specific post-transplant risk scores according to the circulatory support status at transplant: a UNOS cohort analysis.